These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1248916)

  • 1. Analgesic abuse and personality characteristics.
    Hobi V; Ladewig D; Dubach UC; Miest P-Ch ; Ehrensberger T
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):36-41. PubMed ID: 1248916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenacetin abuse V: number of phenacetin abusers in Basel autopsy material 1978-1980. Results of a prospective study].
    Mihatsch MJ; Hofer HO; Korteweg E; Zollinger HU
    Schweiz Med Wochenschr; 1982 Sep; 112(36):1245-8. PubMed ID: 7134951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplantation analgesic dependence in patients who formerly suffered from analgesic neophropathy.
    Furman KI; Galasko GT; Meyers AM; Rabkin R
    Clin Nephrol; 1976 Feb; 5(2):54-6. PubMed ID: 767023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal accumulation of salicylate and phenacetin: possible mechanisms in the nephropathy of analgesic abuse.
    Bluemle LW; Goldberg M
    J Clin Invest; 1969 Nov; 47(11):2507-14. PubMed ID: 5813230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phenacetin abuse II. Chronic renal insufficiency in Basle autopsies].
    Mihatsch MJ; Schmidlin P; Brunner FP; Hofer HO; Six P; Zollinger HU
    Schweiz Med Wochenschr; 1980 Jan; 110(4):116-24. PubMed ID: 6987731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phanacetin abuse III. Malignant urinary tract tumors in phenacetin abuse in Basle 1963-1977].
    Mihatsch MJ; Manz T; Knüsli C; Hofer HO; Rist M; Guetg R; Rutishauser G; Zollinger HU
    Schweiz Med Wochenschr; 1980 Feb; 110(7):255-64. PubMed ID: 7367845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phenacetin-induced hemolytic anemia misdiagnosed as unstable hemoglobinopathy].
    Kato H; Yamasita E; Fujino Y; Tokuhiro H
    Rinsho Ketsueki; 1992 Aug; 33(8):1036-40. PubMed ID: 1404859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is phenacetin responsible for analgesic nephropathy in New South Wales?
    McCredie M; Stewart JH; Mahony JF
    Clin Nephrol; 1982 Mar; 17(3):134-40. PubMed ID: 7067175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pharmacologic effect of flupirtine, a structurally new analgesic].
    Jakovlev V; Sofia RD; Achterrath-Tuckermann U; von Schlichtegroll A; Thiemer K
    Arzneimittelforschung; 1985; 35(1):30-43. PubMed ID: 2985093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obituary to analgesic nephropathy--an autopsy study.
    Mihatsch MJ; Khanlari B; Brunner FP
    Nephrol Dial Transplant; 2006 Nov; 21(11):3139-45. PubMed ID: 16891638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative and positive childhood experiences across developmental periods in psychiatric patients with different diagnoses - an explorative study.
    Saleptsi E; Bichescu D; Rockstroh B; Neuner F; Schauer M; Studer K; Hoffmann K; Elbert T
    BMC Psychiatry; 2004 Nov; 4():40. PubMed ID: 15566566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factor structure of multidimensional personality inventories MMPI, 16-PF, FPI and GT].
    Hobi V
    Psychiatr Neurol Med Psychol (Leipz); 1983 Apr; 35(4):236-43. PubMed ID: 6867209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Particularly severe calcium metabolic disorder in nephropathy from analgesic abuse].
    Jaeger P; Burckhardt P; Wauters JP; Trechsel U; Bonjour JP
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1791-4. PubMed ID: 7178876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analgesic abuse and psychiatric comorbidity in headache patients].
    Radat F; Irachabal S; Swendsen J; Henry P
    Encephale; 2002; 28(5 Pt 1):466-71. PubMed ID: 12386550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenacetin abuse VI: autopsy statistics with special reference to extrarenal findings].
    Mihatsch MJ; Kernen R; Zollinger HU
    Schweiz Med Wochenschr; 1982 Oct; 112(40):1383-8. PubMed ID: 7146855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Abuse of phenacetin-containing analgesics and carcinoma of the renal pelvis (author's transl)].
    Syré G; Matejka M
    Wien Klin Wochenschr; 1981 Jun; 93(13):420-3. PubMed ID: 7269623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.